Market Research Logo

Point of Care Testing Market Size By Product (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Coagulation Testing, Pregnancy and Fertility Testing, Tumour/Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Haematology

Point of Care Testing Market Size By Product (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Coagulation Testing, Pregnancy and Fertility Testing, Tumour/Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Haematology Testing, Drugs-of-Abuse Testing, Faecal Occult Testing), By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Prescription (OTC Testing, Prescription-Based Testing), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing), By End-use (Hospitals, Diagnostic Centres, Research Laboratories, Home-Care Settings) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024

Point of Care Testing Market will exceed USD 34.2 billion by 2024; as per a new research report.

Rise in awareness regarding early disease diagnosis and prevention will boost the demand for point of care molecular diagnostics. Applications such as drug regimen selection, patient stratification, therapeutic monitoring, and detection of predisposition to disease will drive the market growth. Presently, target specific PCR method is used to screen disease causative pathogen. High accuracy level along with more reliability are major factors driving growth of point of care testing market.

High cost of point of care testing devices will be a market hindering factor. The high price of the test and the devices will be unaffordable for the people living in low and middle income countries. Hence, it will lead to decline in product adoption thereby, hampering market growth.

Hematology testing products market held a significant market share in the year 2017 and was valued around USD 2,382.1 million. Increase in prevalence of genetic bleeding disorders such as hemophilia will spur the industry growth. According to the National Hemophilia Foundation, the global prevalence of hemophilia is estimated to be more than 400,000 currently. Hence, rise in number of people suffering from blood disorders will lead to growing hematology testing, augmenting the market growth.

Dipsticks technology market is estimated to grow at a CAGR of 7.5% during the forecast timeframe. Modern automated urine dipstick analyzer provides necessary consistency in timing and color interpretation. Several applications of dipstick in identifying presence of bacterial infection, will drive the growth of dipsticks technology over the forecast period.

OTC testing market was valued around USD 12,403.4 million in the year 2017. The OTC-based tests do not require extensive space like clinical laboratories and its turnaround time is quick. Significant growth in home healthcare sector along with increase in demand and adoption rate of self-tests, especially in case of blood glucose monitoring will enhance the market growth.

The use of point of care testing devices in Drug-of-Abuse (DoA) testing is projected to grow at a CAGR of 7.1% during the forecast period. As per the National Survey on Drug Use and Health (NSDUH), more than 21.5 million Americans were addicted to drugs in the year 2014. Increase in number of people getting addicted drugs will ultimately boost the demand and adoption rate of DoA testing, thereby augmenting the industry growth.

The use of point of care testing in homecare settings was valued at around USD 5,276.2 million in the year 2017. High adoption of devices among the elderly population that are prone to chronic conditions along with reduced physician visits as well as availability of portable, user-friendly and accurate disease monitoring devices will augment the market growth.

UK point of care testing market is estimated to grow at a CAGR of 6.6% during the projection period. Increase in number of people suffering from infectious diseases along with recent technological advancements will drive the point of care testing market in the region.

Japan dominated the Asia Pacific point of care testing market and was valued around USD 843.7 million in the year 2017. Increase in adoption of homecare point of care testing devices and rise in awareness regarding rapid diagnostic testing will augment the point of care testing in the region.

Some of the notable players in point of care testing market participants include Abbott, F. Hoffmann-La Roche Ltd., Johnson and Johnson, Siemens AG, and Abaxis. The major strategy adopted by the key industry players include mergers, acquisitions, partnerships and collaborations. Also, product innovations and new product development will enhance the company’s product portfolio giving them an upper hand among other major market players.


Chapter 1. Methodology
1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Point of care testing industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Technology trends
2.1.4. Prescription trends
2.1.5. Application trends
2.1.6. End-use trends
2.1.7. Regional trends
Chapter 3. Point of Care Testing Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Upward trend in disease prevalence among developing countries such as India
3.3.1.2. Surging number of pathology labs and services equipped with advanced diagnostic equipment in North America
3.3.1.3. Technological advancements
3.3.1.4. Increasing R&D investment
3.3.1.5. Growing geriatric population base globally
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of product development
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By technology
3.4.3. By prescription
3.4.4. By application
3.4.5. By end-use
3.5. Regulatory landscape
3.5.1. U.S.
3.5.2. Europe
3.6. Technology landscape
3.7. Company share analysis, 2017 (by region)
3.7.1. Global market share analysis, 2017
3.7.2. North America
3.7.3. Europe
3.7.4. Asia Pacific
3.7.5. Latin America
3.7.6. Middle East and Africa
3.8. Global market share analysis, by settings and application, 2017
3.9. Company’s global market share analysis, by setting and application, 2017
3.9.1. F. Hoffmann-La Roche Ltd
3.9.2. Abbott
3.9.3. Johnson and Johnson
3.9.4. Siemens AG
3.9.5. Abaxis
3.10. Porter’s analysis
3.11. Competitive landscape, 2017
3.11.1. Business overview
3.11.2. Revenue analysis
3.11.3. Product landscape
3.11.4. Strategy dashboard
3.12. PESTEL analysis
Chapter 4. Point of Care Testing Market, By Product
4.1. Global point of care testing market share, by product, 2017 & 2024
4.2. Glucose monitoring
4.2.1. Market size, by region, 2013 – 2024 ($ Million)
Similar information is provided for
4.2.2. Strips
4.2.3. Meters
4.2.4. Lancets
4.3. Cardiometabolic testing products
4.3.1. Market size, by region, 2013 – 2024 ($ Million)
Similar information is provided for
4.3.2. Cardiac marker testing products
4.3.3. Blood Gas/Electrolytes testing products
4.3.4. HBA1C testing products
4.4. Infectious disease testing products
4.4.1. Market size, by region, 2013 – 2024 ($ Million)
4.4.2. Influenza testing products
Similar information is provided for
4.4.3. HIV testing products
4.4.4. Hepatitis C testing products
4.4.5. Sexually Transmitted Disease (STD) testing products
4.4.6. Healthcare-Associated Infection (HAI) testing products
4.4.7. Respiratory infection testing products
4.4.8. Tropical disease testing products
4.4.9. Other infectious diseases testing products
4.5. Coagulation testing products
4.5.1. Market size, by region, 2013 – 2024 ($ Million)
4.5.2. PT/INR testing products
Similar information is provided for
4.5.3. Activated Clotting Time (ACT/APTT) testing products
4.6. Pregnancy and fertility testing products
4.6.1. Market size, by region, 2013 – 2024 ($ Million)
4.6.2. Pregnancy testing products
Similar information is provided for
4.6.3. Fertility testing products
4.7. Tumor/Cancer marker testing products
4.7.1. Market size, by region, 2013 – 2024 ($ Million)
Similar information is provided for
4.8. Urinalysis testing products
4.9. Cholesterol testing products
4.10. Hematology testing products
4.11. Drug-of-Abuse (DoA) testing products
4.12. Fecal occult testing products
4.13. Other products
Chapter 5. Point of Care Market, By Technology
5.1. Point of care market share by technology, 2017 & 2024
5.2. Lateral flow assays
5.2.1. Market size, by region, 2013 – 2024 ($ Million)
Similar information is provided for
5.3. Dipsticks
5.4. Microfluidics
5.5. Molecular diagnostics
5.6. Immunoassays
5.7. Agglutination assays
5.8. Flow-Through
5.9. Solid phase
5.10. Biosensors
Chapter 6. Point of Care Market, By Prescription
6.1. Point of care market share by prescription, 2017 & 2024
6.2. OTC testing
6.2.1. Market size, by region, 2013 – 2024 ($ Million)
Similar information is provided for
6.3. Prescription-based testing
Chapter 7. Point of Care Market, By Application
7.1. Point of care market share by application, 2017 & 2024
7.2. Cardio metabolic testing
7.2.1. Market size, by region, 2013 – 2024 ($ Million)
Similar information is provided for
7.3. Infectious disease testing
7.4. Nephrology testing
7.5. Drug-of-Abuse (DoA) testing
7.6. Blood glucose testing
7.7. Pregnancy testing
7.8. Cancer biomarker testing
7.9. Other applications
Chapter 8. Point of Care Market, By End-use
8.1. Point of care market share by end-use, 2017 & 2024
8.2. Hospitals
8.2.1. Market size, by region, 2013 – 2024 ($ Million)
Similar information is provided for
8.3. Diagnostic centers
8.4. Research laboratories
8.5. Home-care settings
8.6. Other end-uses
Chapter 9. Point of Care Market, By Region
9.1. Point of care market share by region, 2017 & 2024
9.2. North America
9.2.1. Market size, by country, 2013 – 2024 ($ Million)
9.2.2. Market size, by product, 2013 – 2024 ($ Million)
9.2.2.1. Market size, by glucose monitoring, 2013 – 2024 ($ Million)
9.2.2.2. Market size, by cardiometabolic testing products, 2013 – 2024 ($ Million)
9.2.2.3. Market size, by infectious disease testing products, 2013 – 2024 ($ Million)
9.2.2.4. Market size, by coagulation testing products, 2013 – 2024 ($ Million)
9.2.2.5. Market size, by pregnancy and fertility testing products, 2013 – 2024 ($ Million)
9.2.3. Market size, by technology, 2013 – 2024 ($ Million)
9.2.4. Market size, by prescription, 2013 – 2024 ($ Million)
9.2.5. Market size, by application, 2013 – 2024 ($ Million)
9.2.6. Market size, by end-use, 2013 – 2024 ($ Million)
Similar information is provided for
9.2.7. U.S.
9.2.8. Canada
9.3. Europe
9.3.1. Market size, by country, 2013 – 2024 ($ Million)
9.3.2. Market size, by product, 2013 – 2024 ($ Million)
9.3.2.1. Market size, by glucose monitoring, 2013 – 2024 ($ Million)
9.3.2.2. Market size, by cardiometabolic testing products, 2013 – 2024 ($ Million)
9.3.2.3. Market size, by infectious disease testing products, 2013 – 2024 ($ Million)
9.3.2.4. Market size, by coagulation testing products, 2013 – 2024 ($ Million)
9.3.2.5. Market size, by pregnancy and fertility testing products, 2013 – 2024 ($ Million)
9.3.3. Market size, by technology, 2013 – 2024 ($ Million)
9.3.4. Market size, by prescription, 2013 – 2024 ($ Million)
9.3.5. Market size, by application, 2013 – 2024 ($ Million)
9.3.6. Market size, by end-use, 2013 – 2024 ($ Million)
Similar information is provided for
9.3.7. Germany
9.3.8. UK
9.3.9. France
9.3.10. Spain
9.3.11. Italy
9.4. Asia Pacific
9.4.1. Market size, by country, 2013 – 2024 ($ Million)
9.4.2. Market size, by product, 2013 – 2024 ($ Million)
9.4.2.1. Market size, by glucose monitoring, 2013 – 2024 ($ Million)
9.4.2.2. Market size, by cardiometabolic testing products, 2013 – 2024 ($ Million)
9.4.2.3. Market size, by infectious disease testing products, 2013 – 2024 ($ Million)
9.4.2.4. Market size, by coagulation testing products, 2013 – 2024 ($ Million)
9.4.2.5. Market size, by pregnancy and fertility testing products, 2013 – 2024 ($ Million)
9.4.3. Market size, by technology, 2013 – 2024 ($ Million)
9.4.4. Market size, by prescription, 2013 – 2024 ($ Million)
9.4.5. Market size, by application, 2013 – 2024 ($ Million)
9.4.6. Market size, by end-use, 2013 – 2024 ($ Million)
Similar information is provided for
9.4.7. China
9.4.8. India
9.4.9. Japan
9.4.10. Australia
9.5. Latin America
9.5.1. Market size, by country, 2013 – 2024 ($ Million)
9.5.2. Market size, by product, 2013 – 2024 ($ Million)
9.5.2.1. Market size, by glucose monitoring, 2013 – 2024 ($ Million)
9.5.2.2. Market size, by cardiometabolic testing products, 2013 – 2024 ($ Million)
9.5.2.3. Market size, by infectious disease testing products, 2013 – 2024 ($ Million)
9.5.2.4. Market size, by coagulation testing products, 2013 – 2024 ($ Million)
9.5.2.5. Market size, by pregnancy and fertility testing products, 2013 – 2024 ($ Million)
9.5.3. Market size, by technology, 2013 – 2024 ($ Million)
9.5.4. Market size, by prescription, 2013 – 2024 ($ Million)
9.5.5. Market size, by application, 2013 – 2024 ($ Million)
9.5.6. Market size, by end-use, 2013 – 2024 ($ Million)
Similar information is provided for
9.5.7. Brazil
9.5.8. Mexico
9.6. Middle East and Africa
9.6.1. Market size, by country, 2013 – 2024 ($ Million)
9.6.2. Market size, by product, 2013 – 2024 ($ Million)
9.6.2.1. Market size, by glucose monitoring, 2013 – 2024 ($ Million)
9.6.2.2. Market size, by cardiometabolic testing products, 2013 – 2024 ($ Million)
9.6.2.3. Market size, by infectious disease testing products, 2013 – 2024 ($ Million)
9.6.2.4. Market size, by coagulation testing products, 2013 – 2024 ($ Million)
9.6.2.5. Market size, by pregnancy and fertility testing products, 2013 – 2024 ($ Million)
9.6.3. Market size, by technology, 2013 – 2024 ($ Million)
9.6.4. Market size, by prescription, 2013 – 2024 ($ Million)
9.6.5. Market size, by application, 2013 – 2024 ($ Million)
9.6.6. Market size, by end-use, 2013 – 2024 ($ Million)
Similar information is provided for
9.6.7. South Africa
9.6.8. Saudi Arabia
Chapter 10. Company Profiles
10.1. Abaxis, Inc.
10.1.1. Business overview
10.1.2. Financial data
10.1.3. Product landscape
10.1.4. Strategic outlook
10.1.5. SWOT analysis
Similar information is provided for
10.2. Abbott Laboratories
10.3. Accubiotech Co, Ltd.
10.4. ACON Laboratories, Inc.
10.5. Alere Inc.
10.6. Becton, Dickinson and Company
10.7. Biolytical Laboratories
10.8. bioMrieux SA
10.9. Bio-Rad Laboratories, Inc.
10.10. Danaher Corporation (HemoCue)
10.11. Dexcom, Inc.
10.12. Dragerwerk Ag & Co.
10.13. Johnson & Johnson
10.14. Medtronic
10.15. Meridian Bioscience, Inc.
10.16. Nova Biomedical
10.17. Orasure Technologies, Inc.
10.18. Roche Diagnostic Corporation
10.19. Siemens Healthineers
10.20. Sysmex Corporation
10.21. Trinity Biotech
Data Tables
1. Point of care testing industry 3600 synopsis, 2013 – 2024
2. Global point of care testing market, 2013 – 2017 ($ Million)
3. Global point of care testing market, 2017 – 2024 ($ Million)
4. Global point of care testing market, by product, 2013 - 2017 ($ Million)
5. Global point of care testing market, by product, 2018 - 2024 ($ Million)
6. Global point of care testing market, by technology, 2013 - 2017 ($ Million)
7. Global point of care testing market, by technology, 2018 - 2024 ($ Million)
8. Global point of care testing market, by prescription, 2013 - 2017 ($ Million)
9. Global point of care testing market, by prescription, 2018 - 2024 ($ Million)
10. Global point of care testing market, by application, 2013 - 2017 ($ Million)
11. Global point of care testing market, by application, 2018 - 2024 ($ Million)
12. Global point of care testing market, by end-use, 2013 - 2017 ($ Million)
13. Global point of care testing market, by end-use, 2018 - 2024 ($ Million)
14. Global point of care testing market, by region, 2013 - 2017 ($ Million)
15. Global point of care testing market, by end-user, 2018 - 2024 ($ Million)
16. Industry impact forces
17. Global market share analysis, by setting and application
18. F. Hoffmann-La Roche Ltd.’s global market share analysis, by setting and application
19. Abbott’s global market share analysis, by setting and application
20. Johnson and Johnson’s global market share analysis, by setting and application
21. Siemens AG’s global market share analysis, by setting and application
22. Abaxis’ global market share analysis, by setting and application
23. Glucose monitoring market size, by region, 2013 – 2017 ($ Million)
24. Glucose monitoring market size, by region, 2018 – 2024 ($ Million)
25. Strips market size, by region, 2013 – 2017 ($ Million)
26. Strips market size, by region, 2018 – 2024 ($ Million)
27. Meters market size, by region, 2013 – 2017 ($ Million)
28. Meters market size, by region, 2018 – 2024 ($ Million)
29. Lancets market size, by region, 2013 – 2017 ($ Million)
30. Lancets market size, by region, 2018 – 2024 ($ Million)
31. Cardiometabolic testing products market size, by region, 2013 – 2017 ($ Million)
32. Cardiometabolic testing products market size, by region, 2018 – 2024 ($ Million)
33. Cardiac marker market size, by region, 2013 – 2017 ($ Million)
34. Cardiac marker market size, by region, 2018 – 2024 ($ Million)
35. Blood gas/electrolytes testing products market size, by region, 2013 – 2017 ($ Million)
36. Blood gas/electrolytes testing products market size, by region, 2018 – 2024 ($ Million)
37. HBA1C testing products market size, by region, 2013 – 2017 ($ Million)
38. HBA1C testing products market size, by region, 2018 – 2024 ($ Million)
39. Infectious disease testing products market size, by region, 2013 – 2017 ($ Million)
40. Infectious disease testing products market size, by region, 2018 – 2024 ($ Million)
41. Influenza testing products market size, by region, 2013 – 2017 ($ Million)
42. Influenza testing products market size, by region, 2018 – 2024 ($ Million)
43. HIV testing products market size, by region, 2013 – 2017 ($ Million)
44. HIV testing products market size, by region, 2018 – 2024 ($ Million)
45. Hepatitis C testing products market size, by region, 2013 – 2017 ($ Million)
46. Hepatitis C testing products market size, by region, 2018 – 2024 ($ Million)
47. Sexually transmitted disease (STD) testing products market size, by region, 2013 – 2017 ($ Million)
48. Sexually transmitted disease (STD) testing products market size, by region, 2018 – 2024 ($ Million)
49. Healthcare-associated infection (HAI) testing products market size, by region, 2013 – 2017 ($ Million)
50. Healthcare-associated infection (HAI) testing products market size, by region, 2018 – 2024 ($ Million)
51. Respiratory infection testing products market size, by region, 2013 – 2017 ($ Million)
52. Respiratory infection testing products market size, by region, 2018 – 2024 ($ Million)
53. Tropical disease testing products market size, by region, 2013 – 2017 ($ Million)
54. Tropical disease testing products market size, by region, 2018 – 2024 ($ Million)
55. Other infectious diseases testing products market size, by region, 2013 – 2017 ($ Million)
56. Other infectious diseases testing products market size, by region, 2018 – 2024 ($ Million)
57. Coagulation testing products market size, by region, 2013 – 2017 ($ Million)
58. Coagulation testing products market size, by region, 2018 – 2024 ($ Million)
59. PT/INR testing products market size, by region, 2013 – 2017 ($ Million)
60. PT/INR testing products market size, by region, 2018 – 2024 ($ Million)
61. Activated clotting time (ACT/APTT) testing products market size, by region, 2013 – 2017 ($ Million)
62. Activated clotting time (ACT/APTT) testing products market size, by region, 2018 – 2024 ($ Million)
63. Pregnancy and fertility testing products market size, by region, 2013 – 2017 ($ Million)
64. Pregnancy and fertility testing products market size, by region, 2018 – 2024 ($ Million)
65. Pregnancy testing products market size, by region, 2013 – 2017 ($ Million)
66. Pregnancy testing products market size, by region, 2018 – 2024 ($ Million)
67. Fertility testing products market size, by region, 2013 – 2017 ($ Million)
68. Fertility testing products market size, by region, 2018 – 2024 ($ Million)
69. Tumor/cancer marker testing products market size, by region, 2013 – 2017 ($ Million)
70. Tumor/cancer marker testing products market size, by region, 2018 – 2024 ($ Million)
71. Urinalysis testing products market size, by region, 2013 – 2017 ($ Million)
72. Urinalysis testing products market size, by region, 2018 – 2024 ($ Million)
73. Cholesterol testing products market size, by region, 2013 – 2017 ($ Million)
74. Cholesterol testing products market size, by region, 2018 – 2024 ($ Million)
75. Hematology testing products market size, by region, 2013 – 2017 ($ Million)
76. Hematology testing products market size, by region, 2018 – 2024 ($ Million)
77. Drug-of-Abuse testing products market size, by region, 2013 – 2017 ($ Million)
78. Drug-of-Abuse testing products market size, by region, 2018 – 2024 ($ Million)
79. Fecal occult testing products market size, by region, 2013 – 2017 ($ Million)
80. Fecal occult testing products market size, by region, 2018 – 2024 ($ Million)
81. Other products market size, by region, 2013 – 2017 ($ Million)
82. Other products market size, by region, 2018 – 2024 ($ Million)
83. Lateral flow assays market size, by region, 2013 – 2017 ($ Million)
84. Lateral flow assays market size, by region, 2018 – 2024 ($ Million)
85. Dipsticks market size, by region, 2013 – 2017 ($ Million)
86. Dipsticks market size, by region, 2018 – 2024 ($ Million)
87. Microfluidics market size, by region, 2013 – 2017 ($ Million)
88. Microfluidics market size, by region, 2018 – 2024 ($ Million)
89. Molecular diagnostics market size, by region, 2013 – 2017 ($ Million)
90. Molecular diagnostics market size, by region, 2018 – 2024 ($ Million)
91. Immunoassays market size, by region, 2013 – 2017 ($ Million)
92. Immunoassays market size, by region, 2018 – 2024 ($ Million)
93. Agglutination assays market size, by region, 2013 – 2017 ($ Million)
94. Agglutination assays market size, by region, 2018 – 2024 ($ Million)
95. Flow-through market size, by region, 2013 – 2017 ($ Million)
96. Flow-through market size, by region, 2018 – 2024 ($ Million)
97. Solid phase market size, by region, 2013 – 2017 ($ Million)
98. Solid phase market size, by region, 2018 – 2024 ($ Million)
99. Biosensors market size, by region, 2013 – 2017 ($ Million)
100. Biosensors market size, by region, 2018 – 2024 ($ Million)
101. OTC testing market size, by region, 2013 – 2017 ($ Million)
102. OTC testing market size, by region, 2018 – 2024 ($ Million)
103. Prescription-based testing market size, by region, 2013 – 2017 ($ Million)
104. Prescription-based testing market size, by region, 2018 – 2024 ($ Million)
105. Cardio metabolic testing market size, by region, 2013 – 2017 ($ Million)
106. Cardio metabolic testing market size, by region, 2018 – 2024 ($ Million)
107. Infectious disease testing market size, by region, 2013 – 2017 ($ Million)
108. Infectious disease testing market size, by region, 2018 – 2024 ($ Million)
109. Nephrology testing market size, by region, 2013 – 2017 ($ Million)
110. Nephrology testing market size, by region, 2018 – 2024 ($ Million)
111. Drug-of-abuse testing market size, by region, 2013 – 2017 ($ Million)
112. Drug-of-abuse testing market size, by region, 2018 – 2024 ($ Million)
113. Blood glucose testing market size, by region, 2013 – 2017 ($ Million)
114. Blood glucose testing market size, by region, 2018 – 2024 ($ Million)
115. Pregnancy testing market size, by region, 2013 – 2017 ($ Million)
116. Pregnancy testing market size, by region, 2018 – 2024 ($ Million)
117. Cancer biomarker testing market size, by region, 2013 – 2017 ($ Million)
118. Cancer biomarker testing market size, by region, 2018 – 2024 ($ Million)
119. Other applications market size, by region, 2013 – 2017 ($ Million)
120. Other applications market size, by region, 2018 – 2024 ($ Million)
121. Hospitals market size, by region, 2013 – 2017 ($ Million)
122. Hospitals market size, by region, 2018 – 2024 ($ Million)
123. Diagnostic centers market size, by region, 2013 – 2017 ($ Million)
124. Diagnostic centers market size, by region, 2018 – 2024 ($ Million)
125. Research laboratories market size, by region, 2013 – 2017 ($ Million)
126. Research laboratories market size, by region, 2018 – 2024 ($ Million)
127. Home-care settings market size, by region, 2013 – 2017 ($ Million)
128. Home-care settings market size, by region, 2018 – 2024 ($ Million)
129. Other end-uses market size, by region, 2013 – 2017 ($ Million)
130. Other end-uses market size, by region, 2018 – 2024 ($ Million)
131. North America point of care testing market size, by country, 2013 - 2017 ($ Million)
132. North America point of care testing market size, by country, 2018 - 2024 ($ Million)
133. North America point of care testing market size, by product, 2013 - 2017 ($ Million)
134. North America point of care testing market size, by product, 2018 - 2024 ($ Million)
135. North America point of care testing market size, by glucose monitoring, 2013 - 2017 ($ Million)
136. North America point of care testing market size, by glucose monitoring, 2018 - 2024 ($ Million)
137. North America point of care testing market size, by cardiometabolic testing products, 2013 - 2017 ($ Million)
138. North America point of care testing market size, by cardiometabolic testing products, 2018 - 2024 ($ Million)
139. North America point of care testing market size, by infectious disease testing products, 2013 - 2017 ($ Million)
140. North America point of care testing market size, by infectious disease testing products, 2018 - 2024 ($ Million)
141. North America point of care testing market size, by coagulation testing products, 2013 - 2017 ($ Million)
142. North America point of care testing market size, by coagulation testing products, 2018 - 2024 ($ Million)
143. North America point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 ($ Million)
144. North America point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 ($ Million)
145. North America point of care testing market size, by technology, 2013 - 2017 ($ Million)
146. North America point of care testing market size, by technology, 2018 - 2024 ($ Million)
147. North America point of care testing market size, by prescription, 2013 - 2017 ($ Million)
148. North America point of care testing market size, by prescription, 2018 - 2024 ($ Million)
149. North America point of care testing market size, by application, 2013 - 2017 ($ Million)
150. North America point of care testing market size, by application, 2018 - 2024 ($ Million)
151. North America point of care testing market size, by end-use, 2013 - 2017 ($ Million)
152. North America point of care testing market size, by end-use, 2018 - 2024 ($ Million)
153. U.S. point of care testing market size, by product, 2013 - 2017 ($ Million)
154. U.S. point of care testing market size, by product, 2018 - 2024 ($ Million)
155. U.S. point of care testing market size, by glucose monitoring, 2013 - 2017 ($ Million)
156. U.S. point of care testing market size, by glucose monitoring, 2018 - 2024 ($ Million)
157. U.S. point of care testing market size, by cardiometabolic testing products, 2013 - 2017 ($ Million)
158. U.S. point of care testing market size, by cardiometabolic testing products, 2018 - 2024 ($ Million)
159. U.S. point of care testing market size, by infectious disease testing products, 2013 - 2017 ($ Million)
160. U.S. point of care testing market size, by infectious disease testing products, 2018 - 2024 ($ Million)
161. U.S. point of care testing market size, by coagulation testing products, 2013 - 2017 ($ Million)
162. U.S. point of care testing market size, by coagulation testing products, 2018 - 2024 ($ Million)
163. U.S. point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 ($ Million)
164. U.S. point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 ($ Million)
165. U.S. point of care testing market size, by technology, 2013 - 2017 ($ Million)
166. U.S. point of care testing market size, by technology, 2018 - 2024 ($ Million)
167. U.S. point of care testing market size, by prescription, 2013 - 2017 ($ Million)
168. U.S. point of care testing market size, by prescription, 2018 - 2024 ($ Million)
169. U.S. point of care testing market size, by application, 2013 - 2017 ($ Million)
170. U.S. point of care testing market size, by application, 2018 - 2024 ($ Million)
171. U.S. point of care testing market size, by end-use, 2013 - 2017 ($ Million)
172. U.S. point of care testing market size, by end-use, 2018 - 2024 ($ Million)
173. Canada point of care testing market size, by product, 2013 - 2017 ($ Million)
174. Canada point of care testing market size, by product, 2018 - 2024 ($ Million)
175. Canada point of care testing market size, by glucose monitoring, 2013 - 2017 ($ Million)
176. Canada point of care testing market size, by glucose monitoring, 2018 - 2024 ($ Million)
177. Canada point of care testing market size, by cardiometabolic testing products, 2013 - 2017 ($ Million)
178. Canada point of care testing market size, by cardiometabolic testing products, 2018 - 2024 ($ Million)
179. Canada point of care testing market size, by infectious disease testing products, 2013 - 2017 ($ Million)
180. Canada point of care testing market size, by infectious disease testing products, 2018 - 2024 ($ Million)
181. Canada point of care testing market size, by coagulation testing products, 2013 - 2017 ($ Million)
182. Canada point of care testing market size, by coagulation testing products, 2018 - 2024 ($ Million)
183. Canada point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 ($ Million)
184. Canada point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 ($ Million)
185. Canada point of care testing market size, by technology, 2013 - 2017 ($ Million)
186. Canada point of care testing market size, by technology, 2018 - 2024 ($ Million)
187. Canada point of care testing market size, by prescription, 2013 - 2017 ($ Million)
188. Canada point of care testing market size, by prescription, 2018 - 2024 ($ Million)
189. Canada point of care testing market size, by application, 2013 - 2017 ($ Million)
190. Canada point of care testing market size, by application, 2018 - 2024 ($ Million)
191. Canada point of care testing market size, by end-use, 2013 - 2017 ($ Million)
192. Canada point of care testing market size, by end-use, 2018 - 2024 ($ Million)
193. Europe point of care testing market size, by country, 2013 - 2017 ($ Million)
194. Europe point of care testing market size, by country, 2018 - 2024 ($ Million)
195. Europe point of care testing market size, by product, 2013 - 2017 ($ Million)
196. Europe point of care testing market size, by product, 2018 - 2024 ($ Million)
197. Europe point of care testing market size, by glucose monitoring, 2013 - 2017 ($ Million)
198. Europe point of care testing market size, by glucose monitoring, 2018 - 2024 ($ Million)
199. Europe point of care testing market size, by cardiometabolic testing products, 2013 - 2017 ($ Million)
200. Europe point of care testing market size, by cardiometabolic testing products, 2018 - 2024 ($ Million)
201. Europe point of care testing market size, by infectious disease testing products, 2013 - 2017 ($ Million)
202. Europe point of care testing market size, by infectious disease testing products, 2018 - 2024 ($ Million)
203. Europe point of care testing market size, by coagulation testing products, 2013 - 2017 ($ Million)
204. Europe point of care testing market size, by coagulation testing products, 2018 - 2024 ($ Million)
205. Europe point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 ($ Million)
206. Europe point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 ($ Million)
207. Europe point of care testing market size, by technology, 2013 - 2017 ($ Million)
208. Europe point of care testing market size, by technology, 2018 - 2024 ($ Million)
209. Europe point of care testing market size, by prescription, 2013 - 2017 ($ Million)
210. Europe point of care testing market size, by prescription, 2018 - 2024 ($ Million)
211. Europe point of care testing market size, by application, 2013 - 2017 ($ Million)
212. Europe point of care testing market size, by application, 2018 - 2024 ($ Million)
213. Europe point of care testing market size, by end-use, 2013 - 2017 ($ Million)
214. Europe point of care testing market size, by end-use, 2018 - 2024 ($ Million)
215. Germany point of care testing market size, by product, 2013 - 2017 ($ Million)
216. Germany point of care testing market size, by product, 2018 - 2024 ($ Million)
217. Germany point of care testing market size, by glucose monitoring, 2013 - 2017 ($ Million)
218. Germany point of care testing market size, by glucose monitoring, 2018 - 2024 ($ Million)
219. Germany point of care testing market size, by cardiometabolic testing products, 2013 - 2017 ($ Million)
220. Germany point of care testing market size, by cardiometabolic testing products, 2018 - 2024 ($ Million)
221. Germany point of care testing market size, by infectious disease testing products, 2013 - 2017 ($ Million)
241. UK point of care testing m

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report